MYO1C and myeloid sarcoma: These new microspheres with immobilized p46/Myo1C proteinisolated from blood serum of MS patients were then found to be effective for affinitypurification of the monospecific anti-p46/Myo1C antibodies, reaching a detectionlimit as low as 0.065 μg of protein.